Relationship of dietary intake to hospital admission for coronary heart and vascular disease : the NHANES II natioonal probability studyGARTSIDE, P. S; GLUECK, C. J.Journal of the American College of Nutrition. 1993, Vol 12, Num 6, pp 676-684, issn 0731-5724Article

Modification for cholesterol screening. ReplyKLEVAY, L. M; GLUECK, C. J.The Journal of laboratory and clinical medicine. 1990, Vol 115, Num 2, pp 263-264, issn 0022-2143Article

Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemiasGLUECK, C. J; SPEIRS, J; TRACY, T et al.The Journal of laboratory and clinical medicine. 1990, Vol 115, Num 5, pp 603-609, issn 0022-2143Article

Public cholesterol screening: motivation for participation, follow-up outcome, self-knowledge, and coronary heart disease risk factor interventionSTOCKBRIDGE, H; HARDY, R. I; GLUECK, C. J et al.The Journal of laboratory and clinical medicine. 1989, Vol 114, Num 2, pp 142-151, issn 0022-2143, 10 p.Article

Prospective assessment of coronary heart disease risk factors : The NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-upGARTSIDE, P. S; PING WANG; GLUECK, C. J et al.Journal of the American College of Nutrition. 1998, Vol 17, Num 3, pp 263-269, issn 0731-5724Article

Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein CGLUECK, C. J; FONTAINE, R. N; GUPTA, A et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 12, pp 1470-1472, issn 0026-0495Article

The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemiaGLUECK, C. J; LANG, J; TRACY, T et al.Clinica chimica acta. 1991, Vol 201, Num 1-2, pp 113-122, issn 0009-8981Article

Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic womenGLUECK, C. J; LANG, J; HAMER, T et al.The Journal of laboratory and clinical medicine. 1994, Vol 123, Num 1, pp 59-64, issn 0022-2143Article

Safety and efficacy of treatment of pediatric cholesteryl ester storage disease with lovastatinGLUECK, C. J; LICHTENSTEIN, P; TRACY, T et al.Pediatric research. 1992, Vol 32, Num 5, pp 559-565, issn 0031-3998Article

Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular diseaseGLUECK, C. J; LANG, J. E; TRACY, T et al.The American journal of cardiology. 1999, Vol 83, Num 10, pp 1490-1494, issn 0002-9149Article

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndromeGLUECK, C. J; PING WANG; FONTAINE, R et al.Metabolism, clinical and experimental. 1999, Vol 48, Num 4, pp 511-519, issn 0026-0495Article

Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in childrenBRANDT, G; GRUPPO, R; GLUECK, C. J et al.Thrombosis and haemostasis. 1998, Vol 79, Num 3, pp 567-570, issn 0340-6245Article

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndromeVELAZQUEZ, E. M; MENDOZA, S. G; WANG, P et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 4, pp 454-457, issn 0026-0495Article

Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acidsGLUECK, C. J; STREICHER, P; WANG, P et al.Nutrition (Burbank, Los Angeles County, Calif.). 1996, Vol 12, Num 3, pp 202-205, issn 0899-9007Article

Reversible parotide enlargement and pseudo-Sjögren's syndrome secondary to hypertriglyceridemiaSHEIKH, J. S; SHARMA, M; KUNATH, A et al.Journal of rheumatology. 1996, Vol 23, Num 7, pp 1288-1291, issn 0315-162XArticle

Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis ?GLUECK, C. J; GLUECK, H. I; MIECZKOWSKI, L et al.Thrombosis and haemostasis. 1993, Vol 69, Num 5, pp 460-465, issn 0340-6245Article

High lipoprotein(a) in children from kindreds with parental premature myocardial infarctionMARQUEZ, A; MANDOZA, S; CARRASCO, H et al.Pediatric research. 1993, Vol 34, Num 5, pp 670-674, issn 0031-3998Article

Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarctionMENDOZA, S. G; CARRASCO, H; ZERPA, A et al.Metabolism, clinical and experimental. 1991, Vol 40, Num 4, pp 368-377, issn 0026-0495, 10 p.Article

Effect of ketoconazole on plasma sex hormones, lipids, lipoproteins, and apolipoproteins in hyperandrogenic womenCEDENO, J; MENDOZA, S. G; VELAZQUEZ, E et al.Metabolism, clinical and experimental. 1990, Vol 39, Num 5, pp 511-517, issn 0026-0495, 7 p.Article

Multivariate analysis of lipoprotein cholesterol fractionsVOGLER, G. P; RAO, D. C; LASKARZEWSKI, P. M et al.American journal of epidemiology. 1987, Vol 125, Num 4, pp 706-719, issn 0002-9262Article

Progeny's lipid and lipoprotein levels by parental mortality: the lipid research clinics program prevalence studyGLUECK, C. J; LASKARZEWSKI, P. M; SUCHINDRAN, C. M et al.Circulation. Supplement. 1986, Vol 73, Num 1, pp 51-61, issn 0069-4193Article

Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationshipsMENDOZA, S. G; ZERPA, A; VELAZQUEZ, E et al.International journal of obesity. 1986, Vol 10, Num 6, pp 427-441, issn 0307-0565Article

Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemiaGLUECK, C. J; MELLIES, M. J; DINE, M et al.Pediatrics (Evanston). 1986, Vol 78, Num 2, pp 338-348, issn 0031-4005Article

The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene : An independent risk factor for serious pregnancy complicationsGLUECK, C. J; PHILLIPS, H; CAMERON, D et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 7, pp 845-852, issn 0026-0495Article

Page / 4